Log in

Atlas Arteria Limited (ALX.AX) Stock Forecast, Price & News

Today's Range N/A
50-Day Range
MA: A$6.03
52-Week Range N/A
Volume3.69 million shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend Yield3.35%
Atlas Arteria Limited owns, develops, and operates toll roads. It holds a 13.4% interest in TRIP II, the concessionaire for Dulles Greenway toll road located in northern Virginia, the United States. The company was formerly known as Macquarie Atlas Roads Limited and changed its name to Atlas Arteria Limited in May 2018. Atlas Arteria Limited was incorporated in 2009 and is based in Melbourne, Australia.

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.67 out of 5 stars

Industry, Sector and Symbol

Industry Infrastructure Operations
Phone61 2 8232 7455



Sales & Book Value

Annual Sales$149.99 million
Book ValueA$3.97 per share



Next Earnings DateN/A
OptionableNot Optionable

Receive ALX News and Ratings via Email

Sign-up to receive the latest news and ratings for ALX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Atlas Arteria Limited (ALX.AX) (ASX:ALX) Frequently Asked Questions

What stocks does MarketBeat like better than Atlas Arteria Limited (ALX.AX)?

Wall Street analysts have given Atlas Arteria Limited (ALX.AX) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Atlas Arteria Limited (ALX.AX) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Atlas Arteria Limited (ALX.AX)'s next earnings date?

Atlas Arteria Limited (ALX.AX) is scheduled to release its next quarterly earnings announcement on Thursday, February 25th 2021.
View our earnings forecast for Atlas Arteria Limited (ALX.AX)

How often does Atlas Arteria Limited (ALX.AX) pay dividends? What is the dividend yield for Atlas Arteria Limited (ALX.AX)?

Atlas Arteria Limited (ALX.AX) announced a Interim dividend on Tuesday, September 22nd. Investors of record on Monday, October 5th will be paid a dividend of 0.11 per share on Monday, October 5th. This represents a yield of 1.77%. The ex-dividend date of this dividend is Friday, September 25th.
View Atlas Arteria Limited (ALX.AX)'s dividend history

Who are some of Atlas Arteria Limited (ALX.AX)'s key competitors?

What other stocks do shareholders of Atlas Arteria Limited (ALX.AX) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Atlas Arteria Limited (ALX.AX) investors own include Transurban Group (TCL.AX) (TCL), Sydney Airport Limited (SYD.AX) (SYD), (MQA.AX) (MQA) and Inghams Group Limited (ING.AX) (ING).

Who are Atlas Arteria Limited (ALX.AX)'s key executives?

Atlas Arteria Limited (ALX.AX)'s management team includes the following people:
  • Mr. Graeme Francis Bevans, MD, CEO & Director (Age 62, Pay $2.4M)
  • Ms. Nadine Lennie, Chief Financial Officer (Age 47, Pay $1.03M)
  • Mr. Vincent Portal-Barrault, Chief Operating Officer
  • Phillipa Chen, Head of Investor Relations
  • Mr. Clayton John McCormack BCom, LLB, Company Sec. & Gen. Counsel
  • Navleen Prasad, Public Affairs Mang.

What is Atlas Arteria Limited (ALX.AX)'s stock symbol?

Atlas Arteria Limited (ALX.AX) trades on the ASX under the ticker symbol "ALX."

How big of a company is Atlas Arteria Limited (ALX.AX)?

Atlas Arteria Limited (ALX.AX) has a market capitalization of $0.00 and generates $149.99 million in revenue each year.

What is Atlas Arteria Limited (ALX.AX)'s official website?

The official website for Atlas Arteria Limited (ALX.AX) is www.atlasarteria.com.

How can I contact Atlas Arteria Limited (ALX.AX)?

The company can be reached via phone at 61 2 8232 7455.

This page was last updated on 12/3/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.